Release date: 2026-07-08 11:17:28 Recommended: 239
Laos's pharmaceutical industry started late and remains relatively small in scale; for a long time, domestic drug supply has relied on imports from China, India, and other countries. In recent years, as Laos has increased its opening-up and introduced preferential policies, a number of pharmaceutical companies have chosen to establish factories here, and the sector has shown certain growth momentum. In 2026, Laos officially graduated from the Least Developed Country (LDC) status, and its drug registration standards have been upgraded from the WHO prequalification pathway to ICH standards, with GMP requirements raised simultaneously. The following is an overview of the main legitimate pharmaceutical manufacturers currently operating in Laos.
Lucius Pharmaceuticals (Laos) Co., Ltd. was established in 2020 and is headquartered at No. 26, Thongmang Village, Xaythany District, Vientiane Capital, Laos. As a representative enterprise in Laos's generic drug sector, Lucius Pharmaceuticals originates from its parent company based in Hyderabad, India.
Production Scale: The factory covers an area of approximately 210,000 square meters and houses the Asia-Pacific No.1 Smart Factory, equipped with cutting-edge pharmaceutical machinery from China, the United States, Germany, and other countries, with an annual production capacity exceeding 1.5 billion tablets.
Product Portfolio: Currently produces over 200 generic drugs, covering multiple therapeutic areas including oncology, cardiovascular diseases, diabetes, hematology, dermatology, men's health, and anti-aging. As of June 2024, it has obtained marketing authorizations for 54 anti-cancer drugs, including generic versions of targeted therapies such as sotorasib, osimertinib, cabozantinib, and ivosidenib.
Certifications: Has obtained GMP certification from the Lao Ministry of Health, and its products are registered and approved by the Food and Drug Administration under the Lao Ministry of Health, granting legal production and sales qualifications. In October 2023, the World Health Organization conducted a comprehensive inspection of the Lucius Pharmaceuticals factory and confirmed that it fully complies with WHO standards.
Market Presence: Business has expanded to 12 countries including Thailand, Indonesia, Cambodia, Vietnam, the Philippines, Singapore, Malaysia, Japan, and China.
ASEAN (Laos) Pharmaceutical and Food Co., Ltd. was established in 2012 and is the first pharmaceutical company in Laos to obtain GMP certification. The company currently holds more than 50 approved drug products, covering oncology, chronic diseases, infectious diseases, and other fields.
Element Pharma (Laos) Co., Ltd. was founded in 2019 and is located in the Boten Special Economic Zone, Laos. The company was established with the participation of the technical team from the Artificial Intelligence Bio-medical Technology Research Institute of Nanjing University in China, with a factory area of 2,500 square meters. Element Pharma focuses on the generic manufacturing, production, and sales of anti-tumor and men's health drugs, and has currently exported pharmaceutical products to more than 120 countries and regions across Asia, Africa, Europe, and Latin America.
Laos United Pharmaceutical Group was founded in 2017 as a comprehensive pharmaceutical enterprise integrating R&D, production, and sales. It is currently the largest pharmaceutical company in Laos, accounting for approximately 27% of the domestic drug market share. The Second State Pharmaceutical Factory of Laos was established in the 1970s as a state-owned enterprise directly under the Lao Ministry of Health, producing over 160 types of drugs including infusions, injections, oral tablets, and capsules. Other players include Daewoong Pharmaceuticals, the Third Pharmaceutical Factory of Laos, and others.
Overall, the pharmaceutical industry in Laos is in a phase of rapid development. A number of legitimate manufacturers, represented by Lucius Pharmaceuticals, have formed large-scale production capabilities and have obtained official Lao GMP certifications and product registration numbers.
In recent years, leveraging the World Trade Organization (WTO) patent waiver for···【more】
Recommended:133Release date: 2026-08-05
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic···【more】
Recommended:134Release date: 2026-08-04
Leveraging the WTO patent waiver for least-developed countries (extended to 2033···【more】
Recommended:176Release date: 2026-07-31
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vie···【more】
Recommended:155Release date: 2026-07-28
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Jou···【more】
Recommended:246Release date: 2026-07-24
In recent years, Laos has gradually become a major global supply source for gene···【more】
Recommended:192Release date: 2026-07-22
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently mad···【more】
Recommended:885Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest incr···【more】
Recommended:835Release date: 2024-07-09
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug Information···【more】
Recommended:122Release date: 2026-08-06
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized cont···【more】
Recommended:116Release date: 2026-08-03
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic dru···【more】
Recommended:120Release date: 2026-07-30
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartini···【more】
Recommended:144Release date: 2026-07-29
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and ma···【more】
Recommended:160Release date: 2026-07-21
Lao PDR: Filgotinib Has Been LaunchedBefore initiating filgotinib treatment, str···【more】
Recommended:167Release date: 2026-07-13